Here's A Look At The Drug That Underpins The Latest Aptose Biosciences Inc. Designation
Friday, January 5, 2018 11:44 AM EDT
Aptose Biosciences Inc. picked up Orphan Designation for an early stage development asset on Dec 26, 2017. Here's a look at what that means.
In this article: APTO